A novel, investigational NaV1.8 sodium channel blocker known as VX-548 reduced acute pain after abdominoplasty or bunionectomy at the highest dose, but not at lower doses, two phase II trials showed.

Sodium channels — which transmit sensory information from neurons to the central nervous system — are logical targets for pain treatment. Nonselective sodium channel blockers can reduce pain, but they ...